Is Adipotide FDA approved?
No. This profile records Adipotide as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE FAT BURNER
FTPP, FTTP, Prohibitin-Targeting Peptide
Adipotide is an experimental peptide that takes a unique approach to fat loss. It literally kills fat cells by targeting the blood vessels that feed them. Unlike other weight loss peptides that suppress appetite, Adipotide causes fat cell death (apoptosis) by binding to prohibitin on blood vessel cells in fatty tissue. This is a more aggressive approach and should be considered experimental.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Adipotide as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 0.5-1mg per kg body weight per week (divided doses).
Schedule: daily. Cycle: 4 weeks on, extended break required. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Specifically targets blood vessels supplying fat tissue
Triggers cell death in fat tissue vasculature
Adipocytes die when blood supply is cut off
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.